Physician profile
Jeffrey Roleck
NPI 1619904042
$351.95
in general payments reported to CMS, 2019-2025
10 companies · $121 in 2025
The $121 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.72 · 2021: $14.88 · 2022: $60.83 · 2023: $41.58 · 2024: $50.42 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $59.26 | 2019-2025 | Dyanavel Xr |
| Sobi, INC | $53.16 | 2022-2023 | |
| Ironshore Pharmaceuticals INC. | $50.70 | 2019-2022 | |
| Sanofi Pasteur INC. | $46.56 | 2019-2025 | |
| Cranial Technologies, INC | $40.86 | 2025 | Doc Band |
| Verrica Pharmaceuticals INC. | $26.47 | 2024 | Ycanth |
| Neos Therapeutics, LP | $23.95 | 2024 | Adzenys Xr-Odt |
| Alexion Pharmaceuticals, INC. | $20.16 | 2025 | Koselugo |
| Vertical Pharmaceuticals, LLC | $15.95 | 2025 | Relexxii |
| Supernus Pharmaceuticals, INC. | $14.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Roleck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.